• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Digital Health | News, Analysis, Insights - HIT Consultant

Clearday and Viveon Health Merge to Create Longevity Care Company

by Fred Pennic 04/07/2023 Leave a Comment

Clearday and Viveon Health Merge to Create Longevity Care Company

What You Should Know: - Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special purpose acquisition (SPAC) company have entered into a definitive merger agreement. - The combined company's pro forma equity valuation (assuming no share redemptions) is expected to be approximately $370M. VHAQ currently has $20M held in a trust
Read More

HeartFlow Raises $215M for AI-Powered Cardiac Test

by Fred Pennic 04/06/2023 Leave a Comment

What You Should Know: - HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. - HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients. Expansion Plans The HeartFlow product pipeline is expected to continue to propel the company’s position as a precision diagnostics leader. HeartFlow’s additional product launches will enable the company to further support physicians in their commitment to improve cardiovascular patient outcomes. The new funding will enable HeartFlow to meet the growing demand for its commercial products, support a robust body of growing clinical evidence and advance its comprehensive product portfolio to help physicians to diagnose coronary artery disease (CAD) and guide their treatment decisions.

What You Should Know: - HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. - HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More

PsychoGenics Launches AI Platform to Revolutionize Drug Discovery

by Jasmine Pennic 04/06/2023 Leave a Comment

PsychoGenics Launches AI Platform to Revolutionize Drug Discovery

What You Should Know: - PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform. The platform supports phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets. How eCube Works eCube measures drug-induced changes to EEG spectra data and utilizes machine learning classifiers trained
Read More

Exec Hires: Clinical Trials Marketplace SubjectWell Appoints New CEO

by Executive Digital Health Hires 04/06/2023 Leave a Comment

Clinical Trials Marketplace SubjectWell Appoints New CEO

What You Should Know: - SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. - Fred will joins SubjectWell during a time of growth following the company’s Series B funding in November 2022, with the goal of accelerating technical solutions and building investor relations. Fred Martin Bio Fred brings more than 25 years of experience in
Read More

How AI is Transforming Rare Disease Diagnosis

by Chris Tackaberry, founder and CEO of Clinithink 04/06/2023 Leave a Comment

How AI is Transforming Rare Disease Diagnosis

Collectively rare diseases are anything but rare – they impact 30 million people in the US and ten times that amount globally. And 1 in 3 children suffering from a rare disease will not survive beyond the age of five. One of the biggest challenges facing clinicians is making a quick, accurate diagnosis – on average patients visit eight physicians and receive two to three misdiagnoses before being correctly diagnosed, a process that takes US patients around 7.6 years, and is often referred to
Read More

Patientory Launches Blockchain App Enabling Patients to Earn Money for Their Health Data

by Syed Hamza Sohail 04/05/2023 Leave a Comment

Patientory Launches Blockchain App Enabling Patients to Earn Money for Their Health Data

What You Should Know: Patientory Inc., the creator of a blockchain-based, HIPAA-compliant, private medical data ecosystem, announced today that it has launched two solutions–Patientory Consumer Decentralized Application-designed to help patients more efficiently and securely store and earn money from their medical data and Neith Enterprise Dashboard in partnership with Prosper Healthtech, a community-backed organization committed to equity in Birmingham offering a supportive network of
Read More

ChatGPT Has Potential to Help Cirrhosis, Liver Cancer Patients, Cedars Sinai Study Reveals

by Syed Hamza Sohail 04/05/2023 Leave a Comment

ChatGPT Has Potential to Help Cirrhosis, Liver Cancer Patients

What You Should Know: A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlight the AI system’s potential to play a role in clinical practice. Helping
Read More

Northwell Health Inks 7-Year Deal with Philips for Patient Monitoring

by Fred Pennic 04/04/2023 Leave a Comment

Northwell Health Inks 7-Year Deal with Philips for Enhanced Patient Monitoring

What You Should Know: - Today, Northwell Health announced the 7-year agreement with Philips, which will allow the healthcare system to standardize patient monitoring, enhance patient care and improve patient outcomes while driving interoperability and data innovation. This system will allow Northwell to make use of innovative technologies as they evolve and give them the flexibility to scale their patient monitoring seamlessly in tandem with those new systems.  - This agreement
Read More

Can Technology Live Up to Its Promise for Clinical Trials?

by Stephen Pyke, Chief Clinical Digital and Data Officer, Parexel 04/04/2023 Leave a Comment

Can Technology Live Up to Its Promise for Clinical Trials?

By creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future. For many years, artificial intelligence (AI), machine learning (ML) and natural language processing (NLP) had a reputation in the biopharmaceutical industry as flashy buzzwords, with little concrete evidence to back up their promise. Over time, this lack of understanding has created drawn-out anticipation, leaving many skeptical about the true value of these tools.  As the
Read More

Med Device AVS Raises Additional $8.8M for $28.8M Series B

by Fred Pennic 04/04/2023 Leave a Comment

Med Device AVS Raises Additional $8.8M for $28.8M Series B

What You Should Know: - AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it closed an additional $8.8 million in new financing, bringing its Series B round to $28.8 million total. - The funding will continue to support clinical trials for the company’s device for pulsatile intravascular lithotripsy (PIVL) in peripheral cases, while advancing preclinical work for an expanded
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 305
  • Go to page 306
  • Go to page 307
  • Go to page 308
  • Go to page 309
  • Interim pages omitted …
  • Go to page 779
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HLTH 2025 Coverage

HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |